Stam A G M, Santegoets S J A M, Westers T M, Sombroek C C, Janssen J J W M, Tillman B W, van de Loosdrecht A A, Pinedo H M, Curiel D T, Ossenkoppele G J, Scheper R J, de Gruijl T D
Department of Pathology, Free University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
Br J Cancer. 2003 Oct 6;89(7):1162-5. doi: 10.1038/sj.bjc.6601225.
Vaccination with autologous leukaemia-derived dendritic cells (DC) presents an adjuvant treatment option for chronic myeloid leukaemia (CML). Here, we show that high-efficiency CD40-targeted adenoviral gene transfer of GM-CSF to CML-derived DC induces long-lived maturation in the absence of exogenous cytokines and may thus ensure protracted stimulation of CML-specific T cells upon vaccination.
用自体白血病来源的树突状细胞(DC)进行疫苗接种是慢性粒细胞白血病(CML)的一种辅助治疗选择。在此,我们表明,将GM-CSF进行高效的靶向CD40的腺病毒基因转移至CML来源的DC,可在无外源性细胞因子的情况下诱导长期成熟,因此可能确保接种疫苗后对CML特异性T细胞的持久刺激。